Activation of cell migration via morphological changes in focal adhesions depends on shear stress in MYCN-amplified neuroblastoma cells.
biomechanics
focal adhesion
metastasis
microfluidic device
neuroblastoma
shear stress
Journal
Journal of the Royal Society, Interface
ISSN: 1742-5662
Titre abrégé: J R Soc Interface
Pays: England
ID NLM: 101217269
Informations de publication
Date de publication:
29 03 2019
29 03 2019
Historique:
entrez:
7
3
2019
pubmed:
7
3
2019
medline:
21
5
2020
Statut:
ppublish
Résumé
Neuroblastoma is the most common solid tumour of childhood, and it metastasizes to distant organs. However, the mechanism of metastasis, which generally depends on the cell motility of the neuroblastoma, remains unclear. In many solid tumours, it has been reported that shear stress promotes metastasis. Here, we investigated the relationship between shear stress and cell motility in the MYCN-amplified human neuroblastoma cell line IMR32, using a microfluidic device. We confirmed that most of the cells migrated downstream, and cell motility increased dramatically when the cells were exposed to a shear stress of 0.4 Pa, equivalent to that expected in vivo. We observed that the morphological features of focal adhesion were changed under a shear stress of 0.4 Pa. We also investigated the relationship between malignancy and the motility of IMR32 cells under shear stress. Decreasing the expression of MYCN in IMR32 cells via siRNA transfection inhibited cell motility by a shear stress of 0.4 Pa. These results suggest that MYCN-amplified neuroblastoma cells under high shear stress migrate to distant organs due to high cell motility, allowing cell migration to lymphatic vessels and venules.
Identifiants
pubmed: 30836897
doi: 10.1098/rsif.2018.0934
pmc: PMC6451396
doi:
Substances chimiques
MYCN protein, human
0
N-Myc Proto-Oncogene Protein
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20180934Références
J Cell Sci. 2012 Jul 1;125(Pt 13):3015-24
pubmed: 22797912
J Physiol. 1992 Dec;458:527-38
pubmed: 1338792
Lab Chip. 2008 Aug;8(8):1308-18
pubmed: 18651073
Circ Res. 2006 Feb 3;98(2):245-53
pubmed: 16357306
Cancer Cell. 2007 Jun;11(6):526-38
pubmed: 17560334
Science. 2018 Mar 23;359(6382):1403-1407
pubmed: 29567713
Lab Chip. 2008 Oct;8(10):1733-7
pubmed: 18813398
Nature. 2010 Nov 25;468(7323):580-4
pubmed: 21107430
Oncotarget. 2014 Sep 15;5(17):7625-34
pubmed: 25277194
Mol Biol Cell. 2009 May;20(9):2508-19
pubmed: 19297531
J Biol Chem. 2013 Jul 12;288(28):20248-60
pubmed: 23720740
Front Oncol. 2013 Mar 05;3:44
pubmed: 23467856
PLoS Comput Biol. 2015 Mar 06;11(3):e1004076
pubmed: 25748431
Nature. 2009 Feb 12;457(7231):901-5
pubmed: 19118385
Acta Biomater. 2013 Jul;9(7):7169-77
pubmed: 23567946
FASEB J. 2013 Apr;27(4):1351-61
pubmed: 23254340
Cancer J. 2018 Mar/Apr;24(2):84-92
pubmed: 29601335
Cold Spring Harb Perspect Med. 2013 Oct 01;3(10):a014415
pubmed: 24086065
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2447-52
pubmed: 24550267
Nat Commun. 2017 Jan 18;8:14122
pubmed: 28098159
FEBS Open Bio. 2014 Oct 30;4:966-75
pubmed: 25426416
EMBO J. 2001 Sep 3;20(17):4639-47
pubmed: 11532928
J Pediatr Hematol Oncol. 1999 May-Jun;21(3):181-9
pubmed: 10363850
BMC Biotechnol. 2007 Sep 20;7:60
pubmed: 17883868
New J Phys. 2013 Jan 18;15:015008
pubmed: 25110459
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1506-11
pubmed: 22307605
Clin Exp Metastasis. 2014 Apr;31(4):483-96
pubmed: 24549749
Int J Oncol. 2008 Oct;33(4):815-21
pubmed: 18813796
Biochim Biophys Acta. 2004 Jul 5;1692(2-3):103-19
pubmed: 15246682
Clin Cancer Res. 2008 Jun 1;14(11):3299-305
pubmed: 18519756
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Curr Opin Cell Biol. 2015 Oct;36:13-22
pubmed: 26183445
Lab Chip. 2010 Dec 7;10(23):3277-83
pubmed: 20936235
Oncogene. 1997 Mar 20;14(11):1341-50
pubmed: 9178894
PLoS One. 2013 Apr 10;8(4):e60965
pubmed: 23593358
Biom J. 2008 Jun;50(3):346-63
pubmed: 18481363
Science. 2003 Dec 5;302(5651):1704-9
pubmed: 14657486
Clin Exp Metastasis. 2013 Jun;30(5):555-68
pubmed: 23208732
Neoplasia. 2004 Jul-Aug;6(4):332-42
pubmed: 15256055
JAMA. 1999 Dec 1;282(21):2035-42
pubmed: 10591386
Am J Physiol Cell Physiol. 2006 Oct;291(4):C668-77
pubmed: 16641163
Cancer Manag Res. 2014 Aug 19;6:317-28
pubmed: 25170280
Lab Chip. 2006 Mar;6(3):394-406
pubmed: 16511623
Biochim Biophys Acta Mol Cell Res. 2017 Jan;1864(1):12-22
pubmed: 27773611
Int J Oncol. 2007 May;30(5):1189-96
pubmed: 17390021
Am J Physiol Cell Physiol. 2015 Dec 1;309(11):C736-46
pubmed: 26447202
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3927-32
pubmed: 18310319
J Pediatr Surg. 1993 Jun;28(6):766-9
pubmed: 8331499
Nat Commun. 2017 Apr 12;8:14923
pubmed: 28401884
RNA. 2005 Jun;11(6):985-93
pubmed: 15923380
Mol Biol Cell. 2011 Apr;22(7):964-75
pubmed: 21289086
In Vivo. 2002 Mar-Apr;16(2):77-85
pubmed: 12073775
Lab Chip. 2014 Jun 7;14(11):1880-90
pubmed: 24718713
J Cardiovasc Pharmacol. 2008 Jan;51(1):55-61
pubmed: 18209569